SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-494612
Filing Date
2012-12-07
Accepted
2012-12-07 09:12:54
Documents
11
Period of Report
2012-12-06
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d450707d8k.htm 8-K 19283
2 PRESS RELEASE d450707dex991.htm EX-99.1 14611
3 SLIDE PRESENTATION d450707dex992.htm EX-99.2 25645
4 GRAPHIC g450707ex99_2s1gbgd.jpg GRAPHIC 38990
5 GRAPHIC g450707ex99_2s2gbgd.jpg GRAPHIC 17124
6 GRAPHIC g450707ex99_2s3gbgd.jpg GRAPHIC 17995
7 GRAPHIC g450707ex99_2s4gbgd.jpg GRAPHIC 44796
8 GRAPHIC g450707ex99_2s5gbgd.jpg GRAPHIC 36412
9 GRAPHIC g450707ex99_2s6gbgd.jpg GRAPHIC 27679
10 GRAPHIC g450707ex99_2s7gbgd.jpg GRAPHIC 28550
11 GRAPHIC g450707g95j19.jpg GRAPHIC 8022
  Complete submission text file 0001193125-12-494612.txt   364667
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 121248273
SIC: 2836 Biological Products, (No Diagnostic Substances)